Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BFLY NASDAQ:EYE NYSE:INSP NASDAQ:PRCT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFLYButterfly Network$2.28-0.2%$1.72$1.32▼$4.98$572.71M2.594.20 million shs1.52 million shsEYENational Vision$26.14+2.2%$25.00$9.56▼$29.59$2.07B1.32.09 million shs213,238 shsINSPInspire Medical Systems$77.45+3.0%$84.07$70.77▼$216.01$2.29B1.16744,999 shs75,148 shsPRCTPROCEPT BioRobotics$32.94+0.1%$38.80$32.46▼$103.81$1.84B0.991.02 million shs214,374 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFLYButterfly Network0.00%-2.15%+45.37%+24.66%+25.00%EYENational Vision0.00%-11.47%+11.18%+2.20%+154.58%INSPInspire Medical Systems0.00%-1.72%-6.29%-42.20%-64.32%PRCTPROCEPT BioRobotics0.00%-8.48%-11.36%-43.41%-54.09%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFLYButterfly Network$2.28-0.2%$1.72$1.32▼$4.98$572.71M2.594.20 million shs1.52 million shsEYENational Vision$26.14+2.2%$25.00$9.56▼$29.59$2.07B1.32.09 million shs213,238 shsINSPInspire Medical Systems$77.45+3.0%$84.07$70.77▼$216.01$2.29B1.16744,999 shs75,148 shsPRCTPROCEPT BioRobotics$32.94+0.1%$38.80$32.46▼$103.81$1.84B0.991.02 million shs214,374 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFLYButterfly Network0.00%-2.15%+45.37%+24.66%+25.00%EYENational Vision0.00%-11.47%+11.18%+2.20%+154.58%INSPInspire Medical Systems0.00%-1.72%-6.29%-42.20%-64.32%PRCTPROCEPT BioRobotics0.00%-8.48%-11.36%-43.41%-54.09%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBFLYButterfly Network 2.40Hold$3.0031.87% UpsideEYENational Vision 2.45Hold$24.73-5.39% DownsideINSPInspire Medical Systems 2.40Hold$150.5094.32% UpsidePRCTPROCEPT BioRobotics 2.60Moderate Buy$70.00112.48% UpsideCurrent Analyst Ratings BreakdownLatest BFLY, EYE, INSP, and PRCT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/10/2025INSPInspire Medical SystemsRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$150.0010/8/2025BFLYButterfly NetworkWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025EYENational VisionWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025INSPInspire Medical SystemsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)10/8/2025PRCTPROCEPT BioRoboticsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)10/7/2025INSPInspire Medical SystemsEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$150.00 ➝ $125.009/27/2025BFLYButterfly NetworkWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025EYENational VisionWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025INSPInspire Medical SystemsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)9/27/2025PRCTPROCEPT BioRoboticsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/22/2025INSPInspire Medical SystemsUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy ➝ Neutral$230.00 ➝ $89.00(Data available from 10/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBFLYButterfly Network$82.06M6.98N/AN/A$0.79 per share2.88EYENational Vision$1.89B1.10$1.67 per share15.62$10.37 per share2.52INSPInspire Medical Systems$861.31M2.66$1.76 per share44.00$23.01 per share3.37PRCTPROCEPT BioRobotics$224.50M8.16N/AN/A$7.71 per share4.27Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBFLYButterfly Network-$72.49M-$0.28N/AN/AN/A-71.79%-30.53%-21.80%11/7/2025 (Estimated)EYENational Vision-$28.50M-$0.18N/A96.802.83-0.75%3.56%1.49%11/5/2025 (Estimated)INSPInspire Medical Systems$53.51M$1.7344.7724.052.346.17%10.38%8.93%11/3/2025 (Estimated)PRCTPROCEPT BioRobotics-$91.41M-$1.55N/AN/AN/A-30.60%-23.73%-17.34%10/27/2025 (Estimated)Latest BFLY, EYE, INSP, and PRCT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/7/2025Q3 2025BFLYButterfly Network-$0.07N/AN/AN/AN/AN/A11/5/2025Q3 2025EYENational Vision$0.12N/AN/AN/A$472.98 millionN/A11/3/2025Q3 2025INSPInspire Medical Systems-$0.11N/AN/AN/A$220.39 millionN/A10/27/2025Q3 2025PRCTPROCEPT BioRobotics-$0.41N/AN/AN/A$80.78 millionN/A8/6/2025Q2 2025EYENational Vision$0.12$0.18+$0.06$0.11$469.21 million$486.42 million8/6/2025Q2 2025PRCTPROCEPT BioRobotics-$0.41-$0.35+$0.06-$0.35$75.67 million$79.18 million8/4/2025Q2 2025INSPInspire Medical Systems$0.22$0.45+$0.23-$0.12$214.50 million$217.09 million8/1/2025Q2 2025BFLYButterfly Network-$0.07-$0.06+$0.01-$0.06$23.91 million$23.38 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBFLYButterfly NetworkN/AN/AN/AN/AN/AEYENational VisionN/AN/AN/AN/AN/AINSPInspire Medical SystemsN/AN/AN/AN/AN/APRCTPROCEPT BioRoboticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBFLYButterfly NetworkN/A5.684.14EYENational Vision0.300.520.31INSPInspire Medical SystemsN/A6.144.84PRCTPROCEPT BioRobotics0.139.217.86Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBFLYButterfly Network37.85%EYENational VisionN/AINSPInspire Medical Systems94.91%PRCTPROCEPT BioRobotics89.46%Insider OwnershipCompanyInsider OwnershipBFLYButterfly Network25.18%EYENational Vision2.70%INSPInspire Medical Systems4.10%PRCTPROCEPT BioRobotics17.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBFLYButterfly Network460251.74 million188.35 millionOptionableEYENational Vision13,41179.20 million77.06 millionOptionableINSPInspire Medical Systems1,24629.57 million28.89 millionOptionablePRCTPROCEPT BioRobotics43055.64 million45.96 millionOptionableBFLY, EYE, INSP, and PRCT HeadlinesRecent News About These CompaniesPROCEPT BioRobotics (NASDAQ:PRCT) Earns Sell (E+) Rating from Weiss RatingsOctober 10 at 6:28 AM | marketbeat.comPROCEPT BioRobotics Corporation $PRCT Shares Bought by Blair William & Co. ILOctober 10 at 5:14 AM | marketbeat.comPROCEPT BioRobotics (NASDAQ:PRCT) Reaches New 52-Week Low - Here's What HappenedOctober 8, 2025 | marketbeat.comPROCEPT BioRobotics (PRCT): Evaluating Valuation After Sharp Recent Share Price DeclinesOctober 8, 2025 | finance.yahoo.comProcept BioRobotics: A Strong Challenger Positioned To Be A Future LeaderOctober 6, 2025 | seekingalpha.comPROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Rating of "Moderate Buy" by AnalystsOctober 5, 2025 | marketbeat.comPROCEPT BioRobotics (NASDAQ:PRCT) Sets New 52-Week Low - What's Next?October 1, 2025 | marketbeat.comChicago Capital LLC Boosts Stake in PROCEPT BioRobotics Corporation $PRCTSeptember 30, 2025 | marketbeat.comPROCEPT BioRobotics (NASDAQ:PRCT) Hits New 1-Year Low - Should You Sell?September 20, 2025 | marketbeat.comPROCEPT BioRobotics Updates Executive Severance AgreementsSeptember 18, 2025 | tipranks.comPROCEPT BioRobotics (NASDAQ:PRCT) Stock Price Down 3.5% - Here's What HappenedSeptember 18, 2025 | marketbeat.comMirador Capital Partners LP Buys New Shares in PROCEPT BioRobotics Corporation $PRCTSeptember 18, 2025 | marketbeat.comHarbor Capital Advisors Inc. Purchases Shares of 41,896 PROCEPT BioRobotics Corporation $PRCTSeptember 18, 2025 | marketbeat.comBTIG Research Reaffirms "Neutral" Rating for PROCEPT BioRobotics (NASDAQ:PRCT)September 17, 2025 | marketbeat.comMilitia Capital Partners LP Purchases New Holdings in PROCEPT BioRobotics Corporation $PRCTSeptember 14, 2025 | marketbeat.comPROCEPT BioRobotics Corporation $PRCT Shares Purchased by Osterweis Capital Management Inc.September 14, 2025 | marketbeat.comPROCEPT BioRobotics (NASDAQ:PRCT) Hits New 52-Week Low - Time to Sell?September 13, 2025 | marketbeat.comPROCEPT BioRobotics Corporation $PRCT Shares Bought by Millennium Management LLCSeptember 13, 2025 | marketbeat.comAssessing PROCEPT BioRobotics: Insights From 4 Financial AnalystsSeptember 3, 2025 | benzinga.comOppenheimer Upgrades PROCEPT BioRobotics (PRCT)September 3, 2025 | msn.com3 AI Growth Stocks to Turn $10K Into $50K in Short OrderSeptember 3, 2025 | 247wallst.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesCrowdStrike’s Investor Day Sparks Bullish MomentumBy Chris Markoch | September 26, 2025Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300By Sam Quirke | September 29, 2025Cybersecurity Market Set to Double: This ETF Offers ExposureBy Jordan Chussler | September 24, 2025Wall Street Eyes +30% Upside in Synopsys After Huge Earnings FallBy Leo Miller | September 15, 2025Palantir Stock Eyes New Highs, Boosted by Boeing PartnershipBy Chris Markoch | October 1, 2025BFLY, EYE, INSP, and PRCT Company DescriptionsButterfly Network NYSE:BFLY$2.28 -0.01 (-0.22%) As of 11:02 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.National Vision NASDAQ:EYE$26.16 +0.60 (+2.33%) As of 11:03 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.Inspire Medical Systems NYSE:INSP$77.46 +2.29 (+3.05%) As of 11:02 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.PROCEPT BioRobotics NASDAQ:PRCT$32.97 +0.05 (+0.15%) As of 11:02 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 5 Stocks and ETFs to Weather Volatility as Trade Tensions Rise Levi Strauss Stock Set to Reach New Highs in 2026 Alphabet: The AI Powerhouse Driving Markets Into 2026 Is the Reddit-ChatGPT Love Affair Over? Broadcom Gets Second $420 Target as CPO Win Boosts Outlook AST SpaceMobile's Big Win: Shares Soar on New Deal With Verizon Microsoft 365 Premium Marks the Next Phase of AI Monetization 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
